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Membranes Requires Two Sequential Cleavages,
One Within a Transmembrane Segment
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1993; Hua et al., 1993; Sato et al., 1994). The SREBPs areXianxin Hua, Michael S. Brown,
also believed to activate transcription of genes encodingand Joseph L. Goldstein
other enzymes in the cholesterol biosynthetic pathwayDepartment of Molecular Genetics
(Guan et al., 1995; Ericsson et al., 1996) and two enzymesUniversity of Texas Southwestern Medical Center
of fatty acid biosynthesis, acetyl-CoA carboxylase andDallas, Texas 75235
fatty acid synthetase (Lopez et al., 1996; Bennett et al.,
1995). The DNA targets for these genes differ slightly
from the classic 10 bp SRE-1.Summary
When cells are overloaded with cholesterol, either
through incubation with cholesterol-carrying LDL or bySterol regulatory element binding proteins (SREBPs)
incubation with oxysterols such as 25-hydroxycholes-are transcription factors attached to the endoplasmic
terol, proteolysis of SREBPs is reduced. The SREBPsreticulum. The NH2-segment, which activates tran-
that remain in the nucleus are rapidly degraded in ascription, is connected to membranes by a hairpin
process that is inhibited by N-acetyl-leucine-leucine-anchor formed by two transmembrane sequences and
norleucinal (Wang et al., 1994) and another proteasomea short lumenal loop. Using H-Ras–SREBP-2 fusion
inhibitor, lactacystin (our unpublished data). As a resultproteins, we show that the NH2-segment is released
of this rapid degradation, synthesis of cholesterol andfrom membranes by two sequential cleavages. The
fatty acids rapidly declines, and the number of LDL re-first, regulated by sterols, occurs in the lumenal loop.
ceptors is reduced. This regulatory machinery serves toThe second, not regulated by sterols, occurs within
supply cholesterol and fatty acids to cells when theythe first transmembrane domain. The liberated NH2-
are depleted of sterols and to prevent overload whensegment enters the nucleus and activates genes
sterols are present in excess.controlling cholesterol synthesis and uptake. Certain
The two SREBPs resemble each other in sequencemutant Chinese hamster ovary cells are auxotrophic
throughout their length. They share the three-segmentfor cholesterol because they fail to carry out the sec-
structure and the susceptibility to sterol-regulated pro-ond cleavage; the NH2-segment remains membrane- teolysis. Although they can form heterodimers, such for-bound and transcription is not activated.
mation is not believed to be necessary for action, since
each protein can bind to DNAand stimulate transcription
on its own (Yokoyama et al., 1993; Hua et al., 1993). In
Introduction tissue culture cells, such as HeLa cells and Chinese
hamster ovary (CHO) cells, these two proteins are regu-
Animal cells maintain cholesterol homeostasis by regu- lated in parallel (Wang et al., 1994; Yang et al., 1994,
lating the proteolysis of two membrane-bound tran- 1995). In livers of hamsters (Sheng et al., 1995) and
scription factors, designated sterol regulatory element mice (our unpublished data), coordinant regulation of
binding proteins-1 and -2 (SREBP-1 and SREBP-2; SREBPs is not observed. In liver, the proteolysis of
Wang et al., 1994). These proteins, each about 1150 SREBP-1 occurs in the basal state, and proteolysis
amino acids in length, consist of three segments (Yoko- of SREBP-2 is induced only when the animals are de-
yama et al., 1993; Hua et al., 1993). The NH2-terminal prived of sterols by treatment with bile acid sequestrants
segment of approximately 500 amino acids projects into and inhibitors of 3-hydroxyl-3-methylglutaryl CoA re-
the cytosol. It begins with an acidic transcription-acti- ductase.
vating domain followed by a basic–helix-loop-helix– In addition to the sterol-regulated proteolysis,
leucine zipper. The middle segment is a helical hairpin SREBP-1 and -2 can be cleaved in a sterol-independent
membrane anchor, consisting of two transmembrane manner by CPP-32 and Mch-3, two cysteine proteases
helices separated by a short loop of approximately 30 that are activated when cells undergo programmed cell
aminoacids that projects into the lumen of the endoplas- death (Wang et al., 1995, 1996; Pai et al., 1996). This
mic reticulum (ER) and nuclear envelope. The carboxy apoptosis-induced cleavage occurs at a site in the
(COOH)-terminal segment, about 500 amino acids in SREBP molecule that is distinct from the sterol-regu-
length, also projects into the cytosol, where it plays a lated cleavage site. The functional significance of this
role in sterol-mediated regulation of SREBP cleavage apoptosis-induced cleavage is unknown.
(Hua et al., 1995, 1996). Chin and Chang (1981) originally described a line of
When cells are depleted of cholesterol, one or more mutant CHO cells that is unable to induce transcription
proteases clip each SREBP near the first transmem- of the genes encodingcholesterol biosynthetic enzymes
brane domain, releasing the NH2-terminal segment or the LDL receptor in response to sterol deprivation.
(Wang et al., 1994; Hua et al., 1995). This released seg- More recently, two similar mutant cell lines have been
ment enters the nucleus and activates transcription by developed. These are designated M19 cells (Hasan et
binding to a 10 bp sterol regulatory element (SRE-1) al., 1994) and SRD-6B cells (Evans and Metherall, 1993).
in the promoters of the genes encoding 3-hydroxy-3- They all require exogenous cholesterol for growth. The
methylglutaryl CoA synthase, which is a regulated en- defect in the M19 cells was corrected by transfection
of human genomic DNA (Hasan et al., 1994). Thezyme in the cholesterol biosynthetic pathway, and the
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transfected cells regained the ability to induce transcrip-
tion of the cholesterol biosynthetic enzymes as well as
the LDL receptor. These findings raised the possibility
that the M19 cells (and probably the SRD-6B cells) have
some defect in the cleavage or activation of SREBPs.
Up to now, however, the status of the SREBPs in these
cells has not been determined.
Our laboratory is actively attempting to identify the
sterol-regulated protease or proteases that clip the
SREBPs, to determine the site of clipping, and to deter-
mine the mechanism by which sterols inhibit this pro-
cess. In a recent technical advance, we developed a
transfection system by which to monitor sterol-regu-
lated proteolysis of epitope-tagged SREBPs (Hua et al.,
1996). Human 293 cells are transfected with cDNAs en-
coding tagged SREBP-1 or SREBP-2 under control of
the relatively weak herpes simplex virus (HSV) thymidine
kinase (TK) promoter. This produces an amount of
tagged SREBPs that is roughly equivalent to the amount
of endogenous SREBP. Under these conditions, cleav-
age of the tagged SREBPs takes place in the normal
fashion and is down-regulated by sterols in parallel with
endogenous SREBPs (Hua et al., 1996).
We used the above transfection system to demon-
strate that two elements of the SREBPs are required
for maximal proteolysis, one on either side of the first
transmembrane domain (Hua et al., 1996). One element
is an arginine residue that is near the middle of the
lumenal loop. Replacement of this arginine with an ala-
Figure 1. Model for the Two-Step Proteolytic Cleavage of Mem-
nine abolishes cleavage of SREBP-1a and SREBP-2 by brane-Bound SREBPs
the sterol-regulated protease (Hua et al., 1996). The (A) The first cleavage of the membrane-bound precursor (P form)
other element is the sequence DRSR, which resides on occurs in the lumen of the ER (denoted by the bold arrow) when
cells are depleted of sterols. This reaction requires the presence ofthe NH2-terminal side of the first transmembrane domain
an arginine in the lumenal loop (denoted by R).immediately adjacent to the membrane. Replacement of
(B) The resulting NH2-terminal intermediate (I form) remains mem-the DRSR with two unrelated amino acids (AS) severely
brane-bound until it is cleaved within the first transmembrane do-
reduces the proteolysis of SREBP-1a and -2 (Hua et al., main by a protease that is not regulated by sterols (denoted by the
1996). bold arrow). This reaction requires the DRSR sequence on the NH2-
In the current studies, we have elucidated the reason terminal side of the first transmembrane segment.
(C) After the second cleavage, the mature NH2-terminal portion ofwhy these two sequences are required. We have made
SREBP (M form) is released from the membrane and travels to thethe surprising observation that release of the NH2-termi-
nucleus, where it activates transcription. Although this figure depicts
nal segmentof SREBP-2 requires twosequential proteo- the SREBP as a monomer, it is likely that it exists as a dimer formed
lytic events: an initial sterol-regulated cleavage in the by interactions between the basic–helix-loop-helix–leucine zipper
lumenal loop in the neighborhood of the required argi- domains.
nine and a second cleavage, dependent on DRSR, that
releases the NH2-terminal segment from the membrane. membranes of the ER and nuclear envelope (Figure 1).
Unexpectedly, the second cleavage occurs not at the The first cleavage, which is regulated by sterols, oc-
site of the DRSR, but rather at a site within the first curred at or near the arginine in the lumenal loop that
transmembrane segment. In two mutant lines of choles- had been previously shown to be required for cleavage
terol auxotrophs (SRD-6Band M19 cells), both SREBP-1 (Figure 1A). The NH2-terminal segment produced by this
and -2 failed to be released from the membrane. This cleavage, designated intermediate (I form), remains
failure was not due to a defect in the initial sterol-regu- membrane-bound (Figure 1B). The second cleavage oc-
lated proteolytic step but rather was caused by a lack curs within the transmembrane domain, liberating the
of activity of the second protease that cleaved within mature NH2-terminal fragment (M form) from the mem-
the transmembrane segment. brane (Figure 1C). This cleavage occurs only after the
first cleavage has taken place. In the remaining figures,
we provide evidence to support this model.
Results Figure 2 shows an experiment in which human 293
cells were transfected with a cDNA encoding SREBP-2
To facilitate the interpretation of the subsequent experi- tagged with an NH2-terminal HSV derived epitope and
ments, we present a working model for the two sequen- expressed under control of the HSV TK promoter. The
tial cleavages that liberate the NH2-terminal fragment of cells were incubated under conditions of sterol depriva-
tion, as described in Experimental Procedures (minusSREBP-2 from the precursor (P form) that is bound to
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the cells were incubated in the absence of sterols, the
nuclear extract contained the epitope-tagged mature
form of SREBP-2 (denoted M in Figure 2, lower panel,
lane 3). This form migrated as a broad band at a position
corresponding to approximately 70 kDa. The amount of
the mature form was markedly diminished when sterols
were present (Figure 2, lower panel, lane 4). Lanes 5
and 6 show the results when the transfected cDNA en-
coded a mutant form of SREBP-2 in which the D478RSR
sequence immediately external to the first transmem-
brane domain was changed to AS. As demonstrated
previously (Hua et al., 1996), this mutation markedly di-
minished the amount of mature SREBP-2 in the nucleus
(Figure 2, lower panel, lanes 5 and 6). In the membrane
fraction, there was a corresponding accumulation of a
cleaved intermediate form denoted I (Figure 2, upper
panel, lanes 5 and 6). The amount of the intermediate
form was much greater in the absence of sterols (lane
5) than in their presence (lane 6). When the cDNA en-
coded a mutant in which the lumenal Arg-519 was re-
placed by an Ala, the nuclear form and the membrane-
bound intermediate form were both absent (Figure 2,
lanes 7 and 8).
The intermediate form of SREBP-2 could not be re-
moved from the membrane by extraction with 0.1 M
Na2CO3 (pH 11), raising the possibility that it retained at
least one membrane-spanning region (data not shown,Figure 2. Immunoblot Analysis of 293 Cells Transfected with Mutant
Forms of Epitope-Tagged SREBP-2 but see Figure 5). If this hypothesis is correct, the inter-
mediate form should be longer than the nuclear matureOn day 0, 293 cells were set up at 4 3 105 cells per 60 mm dish in
medium B (Dulbecco’s modified Eagle’s medium containing 100 form. Multiple attempts to demonstrate this size differ-
units/ml penicillin and 100 mg/ml streptomycin) supplemented with ence by SDS–PAGE proved inconclusive, in part be-
10% fetal calf serum. On day 2, cells were transfected with 5 mg/ cause the large size of the fragments (approximately 70
dish of pTK–HSV–BP-2 as previously described (Hua et al., 1995).
kDa) and the diffuseness of the band made it difficultMock-transfected cells (lanes 1 and 2) received 5 mg/dish of empty
to discern a difference of less than 5 kDa. To circumventvector pTK (Hua et al., 1995). After transfection (3 hr), the cells were
this problem, we prepared a chimeric protein in whichchanged to medium B containing 10% newborn calf lipoprotein-
deficient serum, 50 mM compactin, and 50 mM mevalonate in the the NH2-terminal segment of SREBP-2 was replaced
absence (minus) orpresence (plus) of 1 mg/ml 25-hydroxycholesterol with another protein that generated a smaller and less
plus 10 mg/ml cholesterol (sterols) as indicated. All cultures were diffuse NH2-terminal fragment. For this purpose, weadjusted to contain 0.2% ethanol. On day 3, 4 hr before the har-
chose the small GTP binding protein, H-Ras. This pro-vest, all cells received 25 mg/ml N-acetyl-leucine-leucine-norleuci-
tein, of 189 amino acids, is believed to exist as a mono-nal. The cellswere harvested, and the nuclear extract and membrane
mer, and it does not undergo extensive phosphorylation,fractions were prepared as described in Experimental Procedures.
Aliquots of membranes (80 mg) and nuclear extract (60 mg) were making it an ideal replacement for the NH2-terminal do-
subjected to SDS–PAGE and immunoblot analysis with 0.5 mg/ml main of SREBP-2. Although H-Ras normally undergoes
HSV-TagTM antibody. P, I, and M denote the precursor, intermediate, farnesylation and palmitoylation (James et al., 1994),
and mature forms of SREBP-2, respectively. The filters were ex-
these reactions would not be expected to occur withposed to film for 15 s.
the chimeric protein, because the normally farnesylated
cysteine is no longer the fourth residue from the COOH-
sterols) or in the same medium containing an excess terminus.
of 25-hydroxycholesterol and cholesterol (plus sterols). Figure 3A shows the structure of the chimeric H-Ras–
The next day, the cells were harvested. The 105 g mem- SREBP-2 protein (chimeric plasmid A). The NH2-terminal
brane pellet and nuclear extract were solubilized in SDS 472 amino acids of SREBP-2 were replaced with the
loading buffer, subjected to polyacrylamide gel electro- H-Ras sequence preceded by the HSV epitope tag. This
phoresis (PAGE), transferred to nitrocellulose, and incu- protein retained only 11 amino acids of SREBP-2 exter-
bated with a monoclonal antibody directed against the nal to the first transmembrane domain (see sequence,
NH2-terminal HSV epitope tag. In mock-transfected Figure 6). These 11 amino acids included the D478RSR
cells, no specific immunoreactive band was seen in ei- sequence. In a second plasmid, we changed the DRSR
ther the membranes or the nuclear extract (Figure 2, sequence in the chimeric protein to AS (chimeric plas-
lanes 1 and 2). In cells transfected with a cDNA encoding mid B, Figure 3). Both of these plasmids were
wild-type SREBP-2, the membranes contained the pre- transfected into 293 cells, and the Ras protein was visu-
cursor form of SREBP-2 (denoted P in Figure 2, upper alized with the antibody against the epitope tag.
panel). Owing to the presence of the HSV epitope tag, The chimeric Ras plasmid that included the D478RSR
the 125 kDa precursor migrates on SDS gels with a sequence (plasmid A) gave rise to a full-length precursor
form in the membrane with an apparent molecular massmolecular mass of 130 kDa (Hua et al., 1996). When
Cell
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Figure 3. Immunoblot Analysis of 293 Cells Transfected with Epitope-Tagged H-Ras–SREBP-2
(A) Domain structures of human H-Ras–SREBP-2 fusion proteins, indicating the region replaced with human H-Ras and the site of the
D478RSR→AS mutation. The expression vector was constructed as described in Experimental Procedures. Chimeric plasmid A, designated
pTK–HSV– Ras–BP2 (473–1141), was constructed by replacing the NH2-terminal region of pTK–HSV–BP2 (residues 14–472) with human H-Ras
(residues 2–189). Chimeric plasmid B, designated pTK–HSV–Ras–BP2 (473–1141, D478RSR→AS), was constructed by replacing the 4 amino
acid sequence DRSR (residues 478–481) with AS, as described in Experimental Procedures.
(B) Immunoblot analysis of membrane and cytosol fractions from 293 cells transfected with 3 mg/dish of the indicated HSV tagged human
H-Ras–SREBP-2 plasmid. Cells were set up for experiments, transfected with indicated plasmid, incubated in the absence (minus) or presence
(plus) of 3 mg/ml 25-hydroxycholesterol plus 10 mg/ml cholesterol, as indicated. Membrane and cytosol fractions were prepared as described
in Experimental Procedures. Aliquots of 100 mg of membrane protein (upper panel) and 120 mg of cytosol protein (lower panel) were subjected
to SDS–PAGE and immunoblotted with 0.5 mg/ml HSV-TagTM antibody. The filters were exposed to film for 30 s and 15 s for the membrane
and cytosol fractions, respectively. Ras P, Ras I, and Ras M denote the precursor, intermediate, and mature forms of Ras–SREBP-2 fusion
protein, respectively. The asterisk denotes a weak band of unknown significance in the cells transfected with plasmid B.
(C) Aliquots (100 mg protein) of the cytosol fraction (designated C) from lane 3 and the membrane fraction (designated M) from lane 5 in (B)
were subjected to SDS–PAGE in adjacent lanes, followed by immunoblot analysis. Ras I and Ras M denote the intermediate and mature forms
of Ras–SREBP-2 fusion protein, respectively. The filters were exposed to film for 2 min.
of approximately 83 kDa (designated Ras P in Figure H-Ras–SREBP-2 chimeric proteins, we performed side-
by-side SDS–PAGE of the cytosol fraction from cells3B, upper panel). The cytosol contained a mature form
with an apparent molecular mass of 27 kDa (Figure 3B, expressing the wild-type Ras–SREBP-2 sequence and
the membrane fraction from cells expressing thelower panel, lanes 3 and 4). The mature form was present
in the cytosol instead of the nucleus because the chime- DRSR→AS mutant (Figure 3C). Both of these proteins
gave sharp bands whose sizes could be distinguishedric protein lacks a nuclear localization sequence. The
amount of mature form was higher in the absence of from each other. This experiment indicates that the I
form is larger than the M form, and the difference insterols (lane 3) than it was in the presence of sterols
(lane 4), but the difference was not as complete as it apparent molecular mass is about 2–3 kDa. This raised
the possibility that the first cleavage, which generatedwas with native SREBP-2 (compare with Figure 2). No
intermediate form was observed in the membrane (Fig- the intermediate form, took place in the lumenal loop
near Arg-519.ure 3B, upper panel, lanes 3 and 4). When the DRSR
was changed to AS (plasmid B), the cytosol contained To test the above hypothesis, we prepared size stan-
dards consisting of cDNAs encoding H-Ras–SREBP-2no detectable protein of the same size as the mature
form (Figure 3B, lanes 5 and 6), although it did contain fusion proteins with terminator codons in place of Arg-
519 (Stop 519 mutant) and Trp-503 (Stop 503 mutant;a trace amount of a band that migrated faster than the
mature form (designated by asterisk in lane 5). The sig- Figure 4). Cells were transfected with these two cDNAs,
and parallel cells were transfected with a cDNA encod-nificance of this trace band is not clear. In cells express-
ing the DRSR→AS mutant, the membrane fraction con- ing the D478RSR→AS mutant of the Ras–SREBP-2 fusion
protein so as to produce the intermediate membrane-tained a band corresponding to the intermediate form,
designated Ras I. The amount was much greater in the bound fragment. Membranes from the transfected cells
were subjected to SDS–PAGE and blotted with an anti-absence of sterols than in their presence (Figure 3B,
upper panel, lanes 5 and 6). body to the HSV epitope tag on the H-Ras–SREBP-2
fusion proteins. The results showed that the intermedi-To determine the relationship between the sizes of
intermediate and mature forms generated from the ate form of the D478RSR→AS mutant migrated slower
Sterol-Regulated Cleavage of Membrane-Bound SREBP-2
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Figure 4. Estimation of the Size of the Intermediate Form Generated
from the DRSR→AS Mutant of H-Ras–SREBP-2 Fusion Protein
293 cells were transfected with 3 mg/dish of the indicated mutant Figure 5. Extraction of Precursor and Membrane-Bound Intermedi-
form of HSV tagged H-Ras–SREBP-2 plasmid, as described in the ate Forms of H-Ras–SREBP-2 Fusion Protein in Transfected 293
legend to Figure 3. Aliquots of the membrane fraction (42 mg protein Cells
in lanes 1 and 2 and 138 mg protein in lane 3) were subjected to Cells were transfected with 7.5 mg/dish of plasmid B (see Figure
SDS–PAGE in adjacent lanes, followed by immunoblot analysis. The 3A) and incubated for 24 hr in medium B containing 10% newborn
filters were exposed to film for 30 s. Ras I denotes the intermediate calf lipoprotein-deficient serum, 50 mM compactin, and 50 mM mev-
form of the DRSR→AS mutant protein. The asterisk denotes the alonate without sterols. The 105 g membrane fraction from two 60
mature form of Ras–SREBP-2 fusion protein that was found in the mm dishes of cells (360 mg protein) was resuspended in 0.3 ml of
membrane fraction. the following solutions: lane 1, buffer B; lane 2, 0.1 M Na2CO3 (pH
11); lane 3, 1% (v/v) Triton X-100 in buffer B. After incubation for 30
min at 48C in a rotating apparatus, each mixture was centrifuged at
than the Stop 503 mutant and slightly faster than the 105 g for 45 min at 48C in a Beckman TLA 100.2 rotor. Each pellet
was resuspended in 0.3 ml of SDS lysis buffer. Equal aliquots (0.14form that terminated at Arg-519. This suggests that the
ml) of the resuspended pellet (lanes 4–6) and the 105 g supernatantcleavage occurs between Trp-503 and Arg-519. If the
(lanes 1–3) were subjected to SDS–PAGE and immunoblotted withcleavage occurred immediately after Arg-519, we would
1 mg/ml HSV-TagTM antibody. The filters were exposed to film for 5anticipate that the D478RSR→AS intermediate protein s. Ras P and Ras I denote the precursor and intermediate forms of
would be one residue smaller than the Stop 519 protein Ras–SREBP-2 fusion proteins, respectively.
standard, since it lacked two amino acids at the DRSR
site (DRSR replaced with AS) and retained one extra
amino acid at the COOH-terminus (Arg-519). Whether reaction, we prepared a more extensive series of size
standards consisting of truncated Ras–SREBP-2 fusionthese differencesare sufficient toaccount for theslightly
faster mobility on SDS–PAGE is not known. proteins (indicated in Figure 6, top). cDNAs encoding
the full-length fusion protein and the truncated proteinsTo determine whether the intermediate form of the
Ras–SREBP-2 fusion protein remains bound intrinsically were transfected into 293 cells, the membrane and cyto-
sol fractions were obtained, and the sizes of the frag-to membranes, we transfected cells with plasmid B,
which encodes the DRSR→AS mutant (see Figure 3A), ments were estimated by SDS–PAGE and immunoblot-
ting (Figure 6A). The Stop 482 protein, which terminatedand isolated the membrane fraction (Figure 5). Aliquots
of membranes were resuspended in a low salt buffer, a immediately after the final R of the D478RSR sequence,
was found only in the cytosol (Figure 6, lane 3). Thesolution of 0.1 M Na2CO3 at pH 11, or 1% Triton X-100.
The suspensions were spun at 105 g, and equal volumes proteins that terminated at 503, 511, and 519 (Figure 6,
lanes 4–6) all showed membrane precursors as well asof the supernatant and pellet fractions were analyzed
for the I form of Ras–SREBP-2 by SDS–PAGE and immu- cytosolic mature forms, as did the full-length fusion pro-
tein (Figure 6, lanes 2 and 7). The truncated precursorsnoblotting. The vast majority of the I form remained in
the pellet after washing with buffer or 0.1 M Na2CO3 were of varying sizes, consistent with the location of
each stop codon (Figure 6, upper panel), but the mature(Figure 5, lanes 1, 2, 4, and 5), and it was released only
with Triton X-100 (Figure 5, lanes 3 and 6). These findings forms were all of the same size, indicating that these
proteins had each been cleaved at the same point toindicate that the I form retains at least one membrane-
spanning domain, which is consistent with the evidence generate the mature cytosolic fragment (Figure 6, lower
panel, lanes 2 and 4–7). The mature forms migrated morethat the first cleavage event occurs at or near Arg-519
in the lumenal loop. slowly than the Stop 482 standard (Figure 6, lower panel,
lane 3), indicating that the site of cleavage was distalIn order to determine the site of the second cleavage
Cell
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Figure 6. Immunoblot Analysis of 293 Cells
Transfected with Truncated Forms of Epi-
tope-Tagged H-Ras–SREBP-2
A schematic diagram depicting the location
of the stop mutations in the HSV tagged
H-Ras–SREBP-2 fusion protein is shown at
the top.
(A) Cells were transfected with 5 mg/dish of
wild-type or the indicated mutant pTK–HSV–
Ras–BP2 expression vector and incubated
for 24 hr in medium B containing 10% new-
born calf lipoprotein-deficient serum, 50 mM
compactin, and 50 mM sodium mevalonate in
the absence of sterols, as described in the
legend to Figure 2. Aliquots of the membrane
(150 mg protein for lanes 1, 2, and 4–7 and 5
mg for lane 3) and cytosol (200 mg protein for
lanes 1, 2, and 7 and 3–7 mg for lanes 3–6)
fractions were subjected to SDS–PAGE and
immunoblot analysis with 1 mg/ml HSV-TagTM
antibody. The filters were exposed to film for
30s and 15 s for the membrane and cytosol
fractions, respectively.
(B) Aliquots of the cytosol fraction (desig-
nated C; 10 mg protein) and membrane frac-
tion (designated M; 69 mg protein) from the
Stop 503 transfected cells in lane 4 were sub-
jected to SDS–PAGE in adjacent lanes, fol-
lowed by immunoblot analysis. The filters
were exposed to film for 45 s.
to residue 482. The Stop 503 protein terminated immedi- dependent site, we also tested the Stop 519–DRSR→AS
double mutant. This protein did not give rise to a matureately after the first transmembrane domain. It was similar
in size to the mature form. To make certain that the Stop nuclear form (Figure 7, lower panel, lanes 9 and 10). We
interpret this experiment to indicate that the second503 precursor had been cleaved, we performed a side-
by-side electrophoresis of the membrane and cytosolic cleavage reaction is dependent on the DRSR sequence
but that it is not regulated by sterols.fractions from cells expressing this protein. The faster
mobility of the cytosolic product confirmed that the We next set out to determine whether one or both of
the cleavage events was defective in the mutant SRD-cleavage site was proximal to residue 503 (Figure 6B).
Considered together, the data of Figure 6 indicate that 6B and M19 cells, which failed to increase transcription
of cholesterol biosynthetic enzymes or the LDL receptorthe second cleavage site lies between residues 482 and
502, which places it within the first transmembrane se- in response to sterol deprivation. Figure 8 shows an
experiment in which wild-type CHO-7 cells and the twoquence (see sequence, top of Figure 6).
The experiments with the D478RSR→AS mutant indi- mutant cell lines were incubated under one of three
conditions: absence of sterols, absence of sterols andcate that the firstcleavage reaction, which generates the
intermediate form, is regulated by sterols (see Figures 2 presence of the cholesterol synthesis inhibitor com-
pactin, or presence of sterols and compactin. The cellsand 3). We next sought to determine whether the second
cleavage was also sterol-regulated. For this purpose, were harvested, nuclear extracts and membrane pellets
were prepared, and the endogenous SREBP-1 andwe prepared a plasmid encoding a truncated version of
SREBP-2 that terminated at Arg-519 and was therefore SREBP-2 were visualized by SDS–PAGE and immu-
noblotting. CHO-7 cells showed the mature nuclear forma mimic of the intermediate form. In the experiment of
Figure 7, we transfected cells with plasmids encoding of SREBP-1 and -2 in the absence of sterols (Figure 8,
lower panel, lanes 1 and 10). The amount was increasedepitope-tagged full-length SREBP-2, the Stop 519 mu-
tant, a D478RSR→AS mutant, and a double mutant (Stop in the presence of compactin and reduced markedly
when sterols were added (Figure 8, lanes 2, 3, 11, and519/DRSR→AS). As expected, the full-length protein
was cleaved to generate a mature nuclear form, and this 12). The SRD-6B and M19 cells failed to showthe mature
nuclear form of SREBP-1 or -2 under any condition (Fig-was abolished by sterols (Figure 7, lower panel, lanes
3 and 4). The DRSR→AS mutant gave rise to an interme- ure 8, lower panel, lanes 4–9 and 13–18). These mutant
cells did, however, accumulate a proteolyzed mem-diate membrane-bound form in a sterol-regulated fash-
ion (Figure 7, upper panel, lanes 7 and 8). The Stop brane-bound form that was present in the absence of
sterols with or without compactin and was suppressed519 mutant gave rise to a mature nuclear form, but the
amount was not decreased in the presence of sterols completely when sterols were added. This form is desig-
nated I in Figure 8 (upper panel, lanes 4–9 and 13–18).(Figure 7, lower panel, lanes 5 and 6). To make certain
that the mature nuclear form was generated from the The size of the endogenous membrane-bound interme-
diate form in the SRD-6B and M19 cells is similar to thatStop 519 mutant as a result of cleavage at the DRSR
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of the transfected epitope-tagged intermediate form
that accumulated in 293 cells when the DRSR sequence
was mutated to AS (see Figure 2). The intermediate in
the SRD-6B and M19 cells also resisted solubilization
with high salt or Na2CO3 (data not shown). We interpret
these findings to indicate that the SRD-6B and M19
cells carry out the first sterol-regulated cleavage of the
SREBPs but that they lack the ability to carry out the
second DRSR dependent cleavage.
Discussion
The current results reveal a complex mechanism for the
proteolytic release of SREBP-2 from the membranes of
the ER and nuclear envelope. The first event is a cleav-
age at or near Arg-519 in the lumenal loop that generates
an intermediate form of SREBP-2 that remains mem-
brane-bound. This cleavage is accelerated in sterol-
depleted cells, and it is reduced when sterols accumu-
late. The second cleavage, which appears to occur
within the first transmembrane domain, requires the
D478RSR sequence immediately adjacent to this domain.
The second cleavage is not regulated directly by sterols,
but itoccurs only after the first cleavage hastaken place.
After thesecond cleavage, the NH2-terminal mature form
of SREBP-2 leaves the membrane and translocates to
the nucleus (Figure 1).
The two-cleavage mechanism explains our previous
finding that release of the mature form of SREBP-2 re-Figure 7. Immunoblot Analysis of 293 Cells Transfected with the
quires sequences on both sides of the ER membrane,Double Mutant Stop 519–D478RSR→AS Version of Epitope-Tagged
namely D478RSR and Arg-519 (Hua et al., 1996). UnderSREBP-2
ordinary circumstances, the first cleavage is rate-lim-Cells were set up and transfected with 5 mg/dish of the indicated
iting and the second occurs immediately afterwards, sowild-type or mutant form of pTK–HSV–BP2, as described in the
that the intermediate form does not accumulate to anylegend to Figure 2. Aliquots of membranes (80 mg protein) and
nuclear extract (60 mg protein) were subjected to SDS–PAGE and appreciable degree. The two-cleavage mechanism was
immunoblot analysis with 0.5 mg/ml HSV-TagTM antibody. The filters revealed only when we replaced the DRSR sequence
were exposed to film for 7 s. with two unrelated amino acids, thereby slowing the
second cleavage event. Under these conditions we ob-
served the membrane-bound intermediate form, and we
Figure 8. Immunoblot Analysis of Endoge-
nous SREBP-1 and SREBP-2 in Wild-Type
CHO Cells and Mutant CHO Cell Lines That
Are Auxotrophic for Cholesterol (SRD-6B and
M19 Cells)
On day 0, the indicated cells were set up as
described in Experimental Procedures. On
day 2, the medium was changed to medium A
containing 5% fetal calf lipoprotein-deficient
serum and50 mM sodium mevalonate supple-
mented with either 50 mM compactin (plus
compactin) or 1 mg/ml 25-hydroxycholesterol
plus 10 mg/ml cholesterol (plus sterols), as
indicated. On day 3, 4 hr before the harvest,
all cells received 25 mg/ml N-acetyl-leucine-
leucine-norleucinal. The cells were harvest-
ed, fractionated as described in Experimental
Procedures, and aliquots (50 mg protein) of
the membrane and nuclear extract fractions
were subjected to SDS–PAGE. Immuno-
blot analysis was carried out with 15 mg/ml IgG-2A4 for SREBP-1 (A) or 7.5 mg/ml IgG-7D4 antibody for SREBP-2 (B). In (A), filters for both
fractions were exposed to film for 60 s; in (B), filters for the membrane and nuclear extracts fractions were exposed to film for 2 min and 15
s, respectively. P, I, and M denote the precursor, intermediate, and mature forms of SREBP-1 or SREBP-2, respectively. The asterisk in the
membrane fraction of CHO-7 cells (lane 11) denotes a 62 kDa band that migrates faster than the intermediate (I) form of SREBP-2 in lanes
13, 14, 16, and 17. This 62 kDa band in lane 11 is believed to represent contamination with nuclei containing the mature form (M) of SREBP-2.
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were able to show that it was generated only in sterol- Apparently, the sole role of sterols is to regulate the
first cleavage. The Stop 519 mutant lacks the seconddepleted cells.
The finding that the mutant SRD-6B and M19 cells are transmembrane region, and we do not know whether it
was inserted fully into the membrane or merely adherentdefectiveonly in the secondcleavage reaction suggests,
but does not prove, that the two cleavages are carried to the surface. Nevertheless, it was accessible to the
DRSR dependent protease. We also observed cleavageout by different enzymes. We cannot rule out the possi-
bility that a single enzyme carries out both reactions of the truncated forms that stopped at positions 503
and 511, which also may not have been inserted inte-and that the mutation in these cells selectively abolishes
the ability of the protein to carry out the second grally into the membrane (Figure 6). All of these findings
suggest that the second protease may be associatedcleavage.
Based on the size of the intermediate form, we esti- with the cytoplasmic surface of the membrane.
All of the transfection experiments in this paper weremate that the first cleavage reaction occurs at or very
near the required arginine (Arg-519), which is approxi- performed with SREBP-2. We do not yet know whether
SREBP-1 behaves in a similar fashion. The finding thatmately in the middle of the 31 residue lumenal loop
(Figures 1 and 6). Confirmation of this hypothesis will the intermediate form of SREBP-1, as well as that of
SREBP-2, accumulates in the membrane of the mutantrequire isolation of the COOH-terminal product created
by this cleavage and determination of its NH2-terminal SRD-6B and M19 cells (Figure 8) suggests that SREBP-1
also undergoes two sequential cleavages. Indeed,sequence.
The experiment of Figure 6, performed with size stan- SREBP-1 possesses an arginine at a position equivalent
to Arg-519 of SREBP-2, and it also shares the DRSRdards, suggests that the second cleavage occurs be-
tween residues 482 and 502, which places it within the sequence, both of which are required for its release from
membranes (Hua et al., 1996). However, experiments infirst transmembrane domain. It is possible that the pro-
tease is embedded in the membrane with its active site livers of intact animals suggest that SREBP-1 may be
processed to a mature form under conditions in whichcontainedwithin a hydrophilic membrane channel. Alter-
natively, the protease may be located on the surface of the processing of SREBP-2 does not occur (Sheng et
al., 1995). Thus, a firm conclusion as to the mechanismthe membrane, and it might have some mechanism for
extracting the hydrophobic segment from the mem- of processing of SREBP-1 awaits detailed studies with
this protein.brane prior to cleavage. The latter mechanism is favored
by the requirement for the DRSR sequence, which might
be a binding site for such a protease on the external Experimental Procedures
cytoplasmic surface of the membrane.
MaterialsThe COOH-terminal end of the first transmembrane
We obtained HSV-TagTM monoclonal antibody from Novagen;region of SREBP-2 is not precisely defined (see se-
pBluescript KS (plus) vector from Stratagene; SuperSignalTM CL-
quence, top of Figure 6). We believe that this region HRP Substrate System from Pierce; and peroxidase-conjugated af-
terminates at Trp-503, because the corresponding resi- finity-purified donkey anti-mouse IgG from Jackson Immunore-
due is an arginine in human SREBP-1 (see alignment search Laboratories. Other materials were obtained from sources
as previously described (Hua et al., 1995). Fetal calf and newbornin Sato et al., 1994). The residues in this region are
calf lipoprotein-deficient serum (d > 1.215 g/ml) and human LDLhydrophilic, but not charged, and some of them may be
(d 5 1.019–1.063 g/ml) were prepared as previously describedembedded, at least partially, in the lipid bilayer.
(Goldstein et al., 1983). M19 cells were provided by T. Y. Chang and
The intramembrane cleavage of SREBP-2 resembles M. T. Hasan (Dartmouth Medical School).
in some ways the cleavage of the amyloid precursor
protein (APP) that generates the amyloid b protein in Constructions of Plasmids Encoding H-Ras–SREBP-2
Alzheimer’s disease (Selkoe, 1994). This cleavage also Fusion Proteins
pTK–HSV–BP2 is an expression vector that produces epitope-takes place in two steps. First, there is a cleavage on the
tagged human SREBP-2 under control of the HSV TK promoter (Huaexternal surface by a peptidase designated b secretase;
et al., 1996). To construct an expression vector for an H-Ras–this is followed by a second cleavage, within the trans-
SREBP-2 fusion protein, the following steps were used. First, themembrane domain, to yield the amyloid b protein. The
epitope tag was obtained from a previously describedplasmid, pTK–
APP and SREBPs differ in that the NH2-terminus of the HSV–BP1a (Hua et al., 1996), by digestion with NotI and EcoRV.
APP is on the lumenal surface, whereas the NH2-termini This yielded a 0.1 kb NotI–EcoRV fragment that contained the T7
of the SREBPs are on the cytoplasmic surface. More- RNA polymerase promoter followed by two tandem copies of an 11
amino acid HSV epitope from amino acids 265–275 of HSV envelopeover, the APP has only one membrane-spanning region,
glycoprotein D (Isola et al., 1989). Second, the sequence corre-whereas SREBP-1 and -2 have two. As yet, there is no
sponding to amino acids 2–189 of human H-Ras was amplified bymolecular characterization of either of the proteases
polymerase chain reaction of pRcCMV–H-Ras (James et al., 1994)
that act on the APP to produce the amyloid b protein. with an NH2-terminal primer flanked by an EcoRV site and a COOH-
The second cleavage of SREBP-2 clearly cannot take terminal primer flanked by an AvrII site, using conditions described
place unless the first cleavage has occurred. It is possi- previously (Hua et al., 1995, 1996) and digested with EcoRV and AvrII
to isolate a 0.6 kb fragment. Third, the 4.2 kb NotI–XbaI fragment ofble that the first cleavage allows the two transmembrane
human SREBP-2 was isolated from pTK–HSV–BP2 (Hua et al., 1996)regions to separate, thereby allowing the second prote-
and subcloned into a pBluescript KS (plus) vector. The resultingase to gain access to the cleavage site within the trans-
construct was digested with NotI and AvrII to remove the 1.3 kb
membrane domain. This hypothesis is consistent with NotI–AvrII fragment encoding amino acids 14–408 of SREBP-2. The
the observation that the Stop 519 version of SREBP-2 remaining 5.8 kb AvrII–NotI backbone fragment encoding amino
was cleaved in a DRSR dependent fashion and that acids 409–1141 of SREBP-2 was used for further ligation. Fourth,
the above three fragments, namely, the 0.1 kb NotI–EcoRV fragmentthis cleavage was not regulated by sterols (Figure 7).
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from pTK–HSV–BPla, the 0.6 kb EcoRV–AvrII fragment from medium/Ham’s F12 medium [1:1] containing 100 units/ml penicillin
and 100 mg/ml streptomycin sulfate) supplemented with 5% fetalpRcCMV–H-Ras, and the 5.8 kb AvrII–NotI fragment from pTK–HSV–
BP2, were ligated in a single reaction to generate pBluescript HSV– calf lipoprotein-deficient serum. SRD-6B cells and M19 cells were
set up on day 0 at 5 3 105 cells per 100 mm dish in 8 ml mediumRas–BP2. Fifth, pBluescript HSV–Ras–BP2 was digested with NotI
and XbaI to generate a 3.6 kb fragment. Sixth, pTK–HSV–BP2 was A supplemented with 5% fetal calf serum, 1 mM sodium mevalonate,
and 5 mg/ml cholesterol (added in a final concentration of 0.1%digested with NotI and XbaI to remove a 4.2 kb fragment containing
the HSV epitope sequence, after which this sequence was replaced ethanol). On day 2, after incubation for 48 hr, the medium for CHO-7,
SRD-6B, and M19 cells was changed to medium A supplementedwith the 3.6 kb fragment from pBluescript HSV–Ras–BP2. This inter-
mediate plasmid, designated pTK–HSV–Ras–BP2 (409–1141), was with 5% fetal calf lipoprotein-deficient serum and 50 mM sodium
mevalonate in the absence or presence of compactin or sterols, asused to construct by site-directed mutagenesis (see below) the
plasmid pTK–HSV–Ras–BP2 (473–1141). The structure was con- indicated in the figure legend. On day 3, cells were harvested and
fractionated into a nuclear extract and membrane fraction as de-firmed by sequencing all ligation junctions and the entire H-Ras
region. scribed above, with the following modifications. To prepare the
nuclear extract, the cells from 5 dishes were pooled and allowedpTK–HSV–Ras–BP2 (473–1141) encodes an 884 amino acid fusion
protein consisting of, 59 to 39, an initiator methionine, two tandem to swell at 08C for 30 min in 1 ml of buffer B (Hua et al., 1995). The
1000 g nuclear pellet was resuspended in 0.2 ml of buffer C (Huacopies of the HSV epitope (QPELAPEDPED), two novel amino acids
(ID) derived from the BspDI restriction site, human H-Ras (amino et al., 1996). The 1000 g supernatant was used to prepare the mem-
brane fraction by centrifugation at 105 g for 30 min at 48C in aacids 2–189), the two novel amino acids (AS) that correspond to the
NheI restriction site, and human SREBP-2 (amino acids 473–1141) Beckman TLA 100.2 rotor, followed by resuspension of the 105 g
pellet in 0.2 ml of SDS lysis buffer.(Figure 3). pTK–HSV–Ras–BP2 (473–1141, D478RSR→AS) encodes
the same sequence except that the DRSR sequence (amino acids
478–481) in SREBP-2 was changed to AS (Figure 3) by site-directed
Immunoblot Analysismutagenesis.
Samples of nuclear extract, membrane, and cytosol fractions were
mixed with 5X SDS loading buffer (Bollag and Edelstein, 1991), andSite-Directed Mutagenesis
protein concentration was measured with a bicinchoninic acid kitOligonucleotide mutagenesis was carried out with single-stranded
(Pierce). Aliquots of the indicated amount of protein were subjecteduracil-containing DNA (Kunkel et al., 1987) using the Muta-gene
to SDS–PAGE on 8% gels (for SREBPs) and 12.5% gels or 8–12.5%Phagemid Kit (BioRad) as previously described (Hua et al., 1995,
gradient gels (for Ras–SREBP-2 fusion proteins). After electrophore-1996). Each mutant was sequenced to confirm the mutation, and at
sis, the proteins were transferred to Hybond-C extra nitrocelluloseleast two independent clones of each mutant plasmid were indepen-
(Amersham). Immunodetection of transfected human SREBP-2 anddently transfected into 293 cells to confirm the results.
Ras–SREBP-2 fusion proteins was carried out with HSV-TagTM
monoclonal antibody. Immunodetection of endogenous hamster
Cell Culture, Transfection, and Fractionation of 293 Cells
SREBP-1 and -2 was carried out with mouse monoclonal antibod-
Monolayers of human embryonic kidney 293 cells were transfected
ies against the NH2-terminal domains of SREBP-1 (IgG-2A4; Satowith the indicated plasmid and incubated under inducing (minus
et al., 1994) and SREBP-2 (IgG-7D4; Yang et al., 1995), respectively.
sterols) or suppressing conditions (plus sterols) as described pre-
The antibodies were visualized with peroxidase-conjugated affinity-viously (Hua et al., 1995, 1996). Medium for inducing conditions
purified donkey anti-mouse IgG, using the SuperSignalTM CL-HRP
included 10% (v/v) newborn calf lipoprotein-deficient serum, 50 mM
Substrate System according to the instructions of the manufacturer.
compactin, 50 mM sodium mevalonate, and 0.2% (v/v) ethanol. Me-
Gels were calibrated with prestained molecular mass markers (New
dium for suppressing conditions included the same medium plus a
England Biolabs). The blots were exposed to Dupont-NEF 496 film
mixture of 1–3 mg/ml 25-hydroxycholesterol plus 10 mg/ml choles-
at room temperature for the time indicated in the legends.
terol. Cell fractionation was carried out as described previously (Hua
et al., 1995, 1996) with minor modification. To prepare the nuclear
extracts, the cells from duplicate 60 mm dishes were pooled and Acknowledgments
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